Acyclic amine-carboxyboranes were effective anti-inflammatory agents in mice at 8 mg/kg x 2. These amine-carboxyboranes were more effective than the standard indomethacin at 8 mg/kg x 2, pentoxifylline at 50 mg/kg x 2, and phenylbutazone at 50 mg/kg x 2. The heterocyclic amine derivatives as well as amine-carbamoylboranes, carboalkoxyboranes, and cyanoboranes were generally less active.
INTRODUCTION
Amine-cyanoboranes and amine-carbox, yboranes have previously been shown to inhibit induced inflammation in rodents at 10 mg/kg . These studies were expanded to include di-and tripeptides containing boron2, tricyclohexyl-and triphenylphosphine-boranes, carboxyboranes and cyanoboranes3, and boronated 2-deoxynucleosides 4 which demonstrated anti-inflammatory activity in mice. These boron compounds were potent inhibitors of lysosomal hy.drolytic enzyme activities and their release from CFl-mouse hepatic tissue and human PMNs1. The current study extends this investigation to other boron derivatives and additional inflammatory disease models other than induced edema. Selective derivatives of individual chemical classes of boron compounds are examined for their mode of action using isolated enzymes and tissue cultured cells to determine their effects on hydrolytic and proteolytic enzymes and regulatory enzymes of the prostaglandin and leukotriene synthetic pathways.
METHODS AND MATERIALS

Source of Materials
All of the boron derivatives have previously been synthesized and the literature references 5"24 for each compound are listed in , 4, 5, 6, 8, 9, 11, 12, 15, 16, 23, 33, 34, 36, 46, 48, 74, 76, and (-280 g) were administered test drugs 2, 8, 9, 12, 15, 16, 20, 34, or 76 at 8 mg/kg I.P., 1 h before and 3 h after injecting into the pleural cavity 0.05 mi of a 0.316% Evan's blue and carrageenan28. Six hours later, the rats were sacrificed and the fluid collected from the pleural cavity. Control rats produced an average of 2.15 ml of fluid.
Chronic Adjuvant Arthritic Screen. Male Sprague Dawley rats (-180 g) were injected at the base of the tail with 0.2 ml of solution containing 100 mg of dried M._=. but.yricum and 40 mg digitonin in 20 ml of light mineral oil29. Test drugs 2, 7, 8, 12, 20, 34,  (200 i1) of porcine pancreatic elastase (Sigma, Type III) and 20 I1 N-succinyI-L-alanyI-L-alanine-pnitroanilide (Sigma, 100 mg in 5 ml of methyl-2-pyrrolidone). The cleaved product p-nitroanilide was determined at 410 nm for a 3 min period. Collagenase activity was determined at 410 nm for a 3 min period. Collagenase activity was determined by the method of Hu et al. 35 (Table  3) were inhibited by the boron derivatives. Acid p_hosphatase activity in mouse macrophages demonstrated IC50 values between 0.90-7.72 x 10"6M for the boron derivatives tested, for acid cathepsin activity values between 0.76-9.45 x 10"6M, and for aryl sulfatase activity values between 1.37-9.71 10"6M, except for compound 14 (17.6 x 10"6M)._ Human Be Sal cells showed IC50 values for acid phosphatase activity between 1.10-18.3 x 10"6M, for acid cathepsin activity values between 0.85-6.17 x 10"6M, and for aryl sulfatase activity values between 6.07-10.00 x 10"6M. For human leuko_cytes acid phosphatase activity, the IC50 values (Table 4) were between 8.57-10.49 x 10"6M, and acid cathepsin activity values between 5.38-7.71 x 10"6M.
Proteolytic enzyme activities were also reduced by the boron derivatives. Ma_crophage trypsin activity (Table 5) 12  61  49  28  19  197  15  59  86  12  147  16  71  45  2  180  20  13  61  36  23  41  27  81  25  89  30  34  33  61  15  34  65  4  65  18  35  16  36   74  61  46  46  191  48  78  50  134  74  81  40  75  34  279  76  60  50  45  258  77  41  139  78  83  33  15   $7   89  Indomethacin   78  55  12  43  Morphine  213 Phenylbutazone 47
Discussion
The amine-carboxyboranes and related derivatives were not all active as anti-inflammatory agents in rodents at 8 mg/kg x 2. Nevertheless, selected compounds were equally active as the clinically used standards indomethacin, phenylbutazone, and pentoxifylline which afforded 26, 47, and 30% inhibition, respectively of induced inflammation at their therapeutic dose. A number of the amine-carboxyboranes and cyanoborane derivatives were more potent in reducing edema at 8 mg/kg x 2. The mode of actions of the active compounds appears to be similar to those previously reported for cyanoboranes I in that these agents effectively reduced the activities of lysosomal and proteolytic enzymes in a number of cultured cells. Particularly important is their inhibition on these processes in macrophages, leukocytes, and Be Sal osteo-fibrolytic cells. 
